Nurix Therapeutics, Inc. Common stock

NRIXNASDAQ • USD
14.73 USD
↘ 0.75 (4.84%)AT CLOSE (03:59 PM EST)
15.35
↗ 0.62 (4.18%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
15.35
↗ 0.62 (4.18%)
🔴Market: CLOSED

NRIX is currently priced at $14.75. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, exceptional Return on Equity (30.4%) and a bullish Golden Cross on the moving averages. On the valuation side, NRIX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$15.34
High?$15.68
Low?$14.68
Prev. Close?$15.48
Volume?2.2M
Avg. Volume?3.5M
VWAP?$14.99
Rel. Volume?0.61x
Bid / Ask
Bid?$14.65 × 200
Ask?$16.10 × 400
Spread?$1.45
Midpoint?$15.38
Valuation & Ratios
Market Cap?1.6B
Shares Out?109.2M
Float?98.2M
Float %?94.6%
P/E Ratio?5.46
P/B Ratio?1.66
EPS?$2.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Employees
357
Market Cap
1.7B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-07-24
Address
1600 SIERRA POINT PKWY
BRISBANE, CA 94005
Phone: (415) 660-5320
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
100
Momentum?
85
Short Sent.?
50
Piotroski F-Score?4/9Mixed
Altman Z-Score?6.10Safe
Confidence?59%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.29%High
Short Interest?18.9M
Days to Cover?7.2
Free Float98.2M
Avg Daily Volume2.6M
Settlement Date2026-10-30
Financial Health
Current Ratio?8.44Strong
Quick Ratio?8.44Strong
Cash Ratio?5.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
5.5CHEAP▾
P/B?
Peers
100
S&P
83
1.66CHEAP▾
P/S?
Peers
100
S&P
60
2.29CHEAP▾
P/FCF?
Peers
100
S&P
97
4.4CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
3.0CHEAP▾
EV/Sales?
Peers
100
S&P
87
1.27CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
79
30.5%STRONG▾
ROA?
Peers
50
S&P
97
24.7%STRONG▾
Cash Flow & Enterprise
FCF?$369.8M
Enterprise Value?$889.0M
Fundamentals ratios updated end of day